Comprehensive Study Notes on Neurotransmitters and Receptor Physiology

Neurotransmitter Principles and Receptor Structure

• Receptor-Centric Physiology:

  • Although neurotransmitters are grouped into specific structural classes, the specific physiological outcome of neurotransmitter signaling downstream is primarily dictated by the structural properties of the target receptors, rather than the chemical identity of the neurotransmitter itself.
  • A single neurotransmitter can elicit multiple, distinct physiological responses based entirely on the specific receptor subtype to which it binds.

• Acetylcholine ($\text{ACh}$) at the Neuromuscular Junction ($\text{NMJ}$):

  • Binding of $\text{ACh}$ to ionotropic nicotinic acetylcholine receptors ($\text{nAChRs}$) at the $\text{NMJ}$ triggers a rapid influx of sodium ions ($\text{Na}^+$), producing a large excitatory depolarization of the postsynaptic cell.
  • The $\text{nAChR}$ ion channel is permeable to both $\text{Na}^+$ influx and potassium ion ($\text{K}^+$) efflux.
  • Under theoretical equilibrium, $\text{K}^+$ efflux would counteract $\text{Na}^+$ influx and cancel the depolarization. Biologically, this does not occur because $\text{ACh}$ does not remain bound to the receptor long enough for $\text{K}^+$ efflux to attenuate the action potential.

• Mechanisms Regulating $\text{ACh}$ Binding Duration and Action Potential Timing:

  • Receptor Affinity: The $\text{nAChR}$ at the $\text{NMJ}$ possesses a relatively low binding affinity for $\text{ACh}$, allowing $\text{ACh}$ to rapidly unbind from the receptor.
  • Enzymatic Degradation Efficiency: Acetylcholinesterase ($\text{AChE}$), an enzyme localized predominantly at the postsynaptic density, metabolizes $\text{ACh}$ into acetate and choline.
  • $\text{AChE}$ is one of the most catalytically efficient enzymes known, capable of hydrolyzing up to $10{,}000$ molecules of $\text{ACh}$ per second per enzyme molecule (historical estimates cited $5{,}000$\,\text{molecules/s}).
  • Synaptic Geometry: The synaptic cleft at the $\text{NMJ}$ is extremely narrow. Upon release, $\text{ACh}$ is concentrated in a tiny volume, diffuses across the cleft, briefly binds low-affinity receptors, dissociates, and is immediately degraded by $\text{AChE}$.

• Acetylcholine Synthesis, Transport, and Vesicle Recycling:

  • Enzymatic Cleavage: $\text{AChE}$ splits $\text{ACh}$ into choline and acetate within the synaptic cleft.
  • Choline Recycling: Choline is transported back into the presynaptic terminal via the Choline Transporter ($\text{CHT}$), a $\text{Na}^+$-dependent cotransporter that utilizes the downhill $Concentration Gradient$ of $\text{Na}^+$ to drive choline reuptake.
  • Acetate Pool: Acetate is abundantly present inside the cell as a byproduct of cellular respiration.
  • Resynthesis: Acetate and recycled choline are enzymatically recombined into $\text{ACh}$ in the cytoplasm.
  • Vesicular Loading: Regenerated $\text{ACh}$ is loaded into synaptic vesicles via the Vesicular Acetylcholine Transporter ($\text{VAChT}$).
  • Vesicle Membrane Recycling: Presynaptic vesicle membranes undergo endocytosis via clathrin coating, budding off to recycle vesicle membrane proteins for subsequent release cycles.

Nicotinic Acetylcholine Receptor ($\text{nAChR}$) Subunit Diversity

• Pharmacological Classification and Exogenous Ligands:

  • $\text{nAChRs}$ are named for their ability to bind the exogenous alkaloid nicotine.
  • Historical receptor identification and purification relied on exogenous drugs and biological toxins (such as snake venom $\alpha$-neurotoxins) prior to the discovery of endogenous neurotransmitters.

• Subunit Composition and Structural Variations:

  • Ionotropic $\text{nAChRs}$ are multimeric complexes composed of distinct protein subunits arranged around a central ion pore.
  • Conformational opening occurs when alpha-helical transmembrane domains rotate upon ligand binding, opening the central pore to allow $\text{Na}^+$ movement.
  • Across different target tissues and developmental stages, subunit composition varies significantly.
  • Literature identifies $17$ distinct $\text{nAChR}$ subunit genes:
    • $10$ distinct alpha ($\alpha$) subunits.
    • $4$ distinct beta ($\beta$) subunits.
    • $1$ gamma ($\gamma$) subunit.
    • $1$ delta ($\delta$) subunit.
    • $1$ epsilon ($\epsilon$) subunit.
  • Functional receptors require combinations of these subunits (typically pentameric assemblies forming the central channel pore).

• Developmental and Functional Adaptations:

  • Fetal $\text{nAChR}$ isoforms contain specific subunit combinations (such as the inclusion of a $\gamma$ subunit instead of an $\epsilon$ subunit) that confer higher affinity for $\text{ACh}$ compared to adult variants.
  • High ligand affinity is not inherently advantageous; excessively high affinity prevents neurotransmitter dissociation, resulting in persistent channel activation or receptor desensitization.
  • Receptor-ligand affinity is dynamically influenced by environmental factors including temperature, $\text{pH}$, and local chemical modulators.
  • Structural variation in binding sites alters ligand affinity, whereas structural variation in the channel pore and selectivity filter alters ion selectivity and hydration shell removal during ion passage.
  • Receptor diversity permits functional specialization across effector tissues (e.g., voluntary control in skeletal muscle versus autorhythmic regulation in cardiac tissue).

Muscarinic Acetylcholine Receptor ($\text{mAChR}$) Signaling Pathways

• Metabotropic Structure:

  • $\text{mAChRs}$ are single monomeric G-protein coupled receptors (GPCRs), where one gene encodes a complete functional receptor (unlike $\text{nAChRs}$, where one gene encodes a single subunit of a multimeric channel).
  • There are $5$ distinct muscarinic receptor subtypes, designated $\text{M}_1$ through $\text{M}_5$.

• $\text{M}_1$, $\text{M}_3$, and $\text{M}_5$ Receptor Subgroup:

  • G-Protein Coupling: Coupled to the $G_q$ class of G-proteins.
  • Downstream Cascade: Activation of $\text{M}_1$, $\text{M}_3$, or $\text{M}_5$ stimulates the membrane-bound enzyme Phospholipase C ($\text{PLC}$).
  • $\text{PLC}$ hydrolyzes phosphatidylinositol 4,5-bisphosphate ($\text{PIP}_2$) into two second messengers:
    1. Diacylglycerol ($\text{DAG}$), which remains in the membrane.
    2. Inositol 1,4,5-trisphosphate ($\text{IP}_3$), a soluble, diffusible molecule.
  • $\text{IP}_3$ diffuses to the endoplasmic reticulum ($\text{ER}$) and opens $\text{IP}_3$--gated $\text{Ca}^{2+}$ channels, releasing stored calcium into the cytoplasm.
  • Produces a substantial increase in intracellular free $\text{Ca}^{2+}$, initiating downstream cellular events.

• $\text{M}_2$ and $\text{M}_4$ Receptor Subgroup:

  • G-Protein Coupling: Coupled to inhibitory G-proteins ($G_i$).
  • Downstream Cascade: Activation inhibits adenylyl cyclase, reducing the production of cyclic adenosine monophosphate ($\text{cAMP}$) and decreasing Protein Kinase A ($\text{PKA}$) activity.
  • Ion Channel Modulation: Dissociated $G_{\beta\times\frac{}{}}$ subunits diffuse laterally in the plasma membrane to open G-protein coupled inwardly rectifying potassium ($\text{GIRK}$) channels.
  • The resulting $\text{K}^+$ efflux hyperpolarizes the membrane, decreasing cellular excitability by lowering the resting membrane potential.

• Physiological Regulation of Heart Rate:

  • Intrinsic autorhythmic cardiac pacemaking generates an unmodulated heart rate of approximately $100\text{--}120\,\text{bpm}$.
  • Parasympathetic nervous system activation releases $\text{ACh}$ onto cardiac $\text{M}_2$ receptors.
  • $\text{M}_2$ activation hyperpolarizes sinoatrial node cells, reducing firing frequency to maintain normal resting heart rates of $60\text{--}100\,\text{bpm}$.

Glutamate Dynamics and Ionotropic Glutamate Receptors

• Glutamate Synthesis and Astrocyte-Neuron Shuttle:

  • Glutamate is the primary excitatory neurotransmitter in the central nervous system.
  • Synthesized from glutamine via the mitochondrial enzyme glutaminase, or generated as a byproduct of cellular respiration.
  • Concentrated into presynaptic vesicles via Vesicular Glutamate Transporters ($\text{VGLUT}$).
  • Absence of Synaptic Degradation: Unlike $\text{ACh}$, glutamate is not enzymatically degraded within the synaptic cleft.
  • Astrocytic Reuptake: Excitatory Amino Acid Transporters ($\text{EAATs}$) on neighboring astrocytes rapidly clear glutamate from the synaptic cleft to prevent excitotoxicity.
  • Inside astrocytes, glutamate is converted back into non-toxic glutamine by glutamine synthetase.
  • Glutamine is exported from astrocytes via the $\text{SN1}$ transporter ($\text{SLC38A3}$) and imported into presynaptic neurons via neuronal glutamine transporters, completing the glutamate-glutamine cycle.

• Ionotropic Glutamate Receptor Classes:

  • There are three functional classes of ligand-gated ionotropic glutamate receptors, all eliciting excitatory postsynaptic responses:
    1. $\text{AMPA}$ Receptors ($\alpha$-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors).
    2. $\text{NMDA}$ Receptors ($N$-methyl-D-aspartate receptors).
    3. Kainate Receptors.

• Mechanisms of Long-Term Potentiation ($\text{LTP}$):

  • Repeated high-frequency activation of excitatory synapses leads to $\text{LTP}$, a form of activity-dependent synaptic plasticity characterized by persistent structural and molecular strengthening of the synapse.
  • $\text{AMPA}$ Receptor Role: $\text{AMPA}$ receptors possess two distinct glutamate binding sites. Upon binding glutamate, $\text{AMPA}$ receptors open to allow rapid $\text{Na}^+$ influx, generating localized postsynaptic depolarization.
  • $\text{NMDA}$ Receptor as a Coincidence Detector: The $\text{NMDA}$ receptor channel requires three distinct conditions to open:
    1. Binding of glutamate.
    2. Binding of glycine (acting as a necessary co-agonist).
    3. Postsynaptic membrane depolarization.
  • Magnesium Block Removal: At resting membrane potentials, a magnesium ion ($\text{Mg}^{2+}$) is electrostatically lodged within the $\text{NMDA}$ receptor pore, blocking ion conduction.
  • Sufficient prior depolarization supplied by neighboring $\text{AMPA}$ receptors repels the $\text{Mg}^{2+}$ ion out of the pore into the extracellular space.
  • Calcium Signal Cascade: Once unblocked, $\text{NMDA}$ receptors conduct a large influx of $\text{Ca}^{2+}$.
  • Intracellular $\text{Ca}^{2+}$ acts as a second messenger, activating downstream protein kinases (such as $\text{CaMKII}$) and calcium-binding proteins.
  • Kinase signaling induces the exocytosis and insertion of additional $\text{AMPA}$ receptors into the postsynaptic membrane, durably increasing the sensitivity of the synapse to future glutamate release.

Metabotropic Glutamate Receptors ($\text{mGluRs}$) and Inhibitory Transmitters

• Metabotropic Glutamate Receptors ($\text{mGluRs}$):

  • $\text{mGluRs}$ are ancient GPCRs conserved throughout animal evolution, present even in basal metazoans such as sea sponges ($\text{Porifera}$).
  • Depending on the associated G-protein, $\text{mGluRs}$ can mediate excitatory or inhibitory downstream signaling:
    • Group I $\text{mGluRs}$ ($\text{mGluR}_1$, $\text{mGluR}_5$): Coupled to $G_q$, activating $\text{PLC}$ to cleave $\text{PIP}_2$ into $\text{IP}_3$ and $\text{DAG}$, elevating intracellular $\text{Ca}^{2+}$.
    • Group II ($\text{mGluR}_2$, $\text{mGluR}_3$) and Group III ($\text{mGluR}_4$, $\text{mGluR}_6$, $\text{mGluR}_7$, $\text{mGluR}_8$) $\text{mGluRs}$: Coupled to $G_i$, inhibiting adenylyl cyclase and lowering cyclic messenger levels.
  • In the inactive state, GPCRs exist loosely associated with their G-protein complexes; ligand binding induces structural realignments that tightly bind and activate the G-protein.

• GABA Synthesis, Transport, and $\text{GABA}_A$ Signaling:

  • $\gamma$-Aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system, synthesized directly from glutamate by the enzyme glutamate decarboxylase ($\text{GAD}$).
  • Loaded into synaptic vesicles via the Vesicular Inhibitory Amino Acid Transporter ($\text{VIAAT}$, also termed $\text{VGAT}$).
  • Cleared from the cleft by GABA transporters ($\text{GATs}$) into surrounding glial cells and presynaptic terminals for recycling.
  • $\text{GABA}_A$ Receptor Mechanics: Ionotropic $\text{GABA}_A$ receptors are ligand-gated chloride channels ($\text{Cl}^-$).
  • Binding of GABA opens the channel, allowing $\text{Cl}^-$ to flow down its concentration gradient into the postsynaptic cell.
  • The influx of negative $\text{Cl}^-$ ions causes membrane hyperpolarization, generating inhibitory postsynaptic potentials ($\text{IPSPs}$) that keep the cell potential below the action potential threshold.

• Glycine Synthesis, Function, and Pharmacological Inhibition:

  • Glycine is the smallest amino acid, serving as the primary inhibitory neurotransmitter in the spinal cord and brainstem.
  • Synthesized from glucose metabolism intermediates or directly from serine via the enzyme serine hydroxymethyltransferase.
  • Concentrated into synaptic vesicles via $\text{VIAAT}$, released into the cleft, and cleared by $\text{Na}^+$-dependent glycine cotransporters.
  • Binds ionotropic glycine receptors, opening selective $\text{Cl}^-$ channels to drive postsynaptic hyperpolarization.
  • Physiological Significance of Ongoing Inhibition: Ongoing tonic inhibition by GABA and glycine is required to suppress background motor and neuronal excitability to maintain homeostasis.
  • Strychnine Toxicity: Strychnine acts as a potent competitive antagonist of ionotropic glycine receptors, blocking glycine-mediated $\text{Cl}^-$ influx.
  • Abolishing glycine inhibition causes unchecked, continuous muscle contraction and painful, seizure-like spasms across motor units while the individual remains fully conscious.